Clinical Trial Update: AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia [Phase 1, Phase 2]

View source ↗

Summary

AZD0486 is being studied as a monotherapy in B-cell acute lymphoblastic leukemia in Phase 1/2 trials and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• AZD0486 (AZD0486)

Snippet

Sponsor: AstraZeneca | Conditions: B-cell Acute Lymphoblastic Leukemia (B-ALL) | Phase 1, Phase 2 | Status: RECRUITING